Moreno C, Byrd JC, Hillmen P, et al. Ibrutinib in previously treated chronic lymphocytic leukemia updated efficacy and safety of the RESONATE study with up to four years of follow-up. EHA 2017, abstract S769.
Uitkomsten van COVID-19 na hematopoëtische stamceltransplantatie
apr 2021 | Leukemie, Lymfoom, MM, MPN, Stamceltransplantatie, Virale infecties